Tekla Life Sciences Investors
General ticker "HQL" information:
- Sector: Financials
- Industry: Asset Management
- Capitalization: $455.1M (TTM average)
Tekla Life Sciences Investors follows the US Stock Market performance with the rate: 62.4%.
Estimated limits based on current volatility of 1.3%: low 17.06$, high 17.50$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-05-21, amount 0.56$ (Y12.54%)
Short-term HQL quotes
Long-term HQL plot
Financial data
| YTD | 2025-09-30 |
|---|---|
| Operating Revenue | $86.39MM |
| Operating Expenses | $0.79MM |
| Operating Income | $85.59MM |
| Income(Loss) | $85.59MM |
| Net Income(Loss)* | $85.59MM |
| Stockholders Equity | $513.66MM |
| Assets | $515.38MM |
| Operating Cash Flow | $-2.32MM |
| Capital expenditure | $0.00MM |
| Investing Cash Flow | $25.21MM |
| Financing Cash Flow | $-31.63MM |
| Earnings Per Share** | $2.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.